Pharmaceutical cocrystallization: an effective approach to modulate the physicochemical properties of solid-state drugs
Pharmaceutical cocrystallization affords an opportunity to modify the physicochemical properties of a solid-state drug without covalent modification of its molecular structure. This review presents an update on various applications of pharmaceutical cocrystallization with considerations on both cocr...
Saved in:
| Published in | CrystEngComm Vol. 2; no. 36; pp. 5292 - 5316 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Cambridge
Royal Society of Chemistry
2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Pharmaceutical cocrystallization affords an opportunity to modify the physicochemical properties of a solid-state drug without covalent modification of its molecular structure. This review presents an update on various applications of pharmaceutical cocrystallization with considerations on both cocrystals and salts, focusing on the property modification relevant to clinical efficacy and safety, and manufacturability of drugs. Some prominent examples of drug cocrystals/salts, which exhibit improved solubility and/or permeability and pharmacokinetics, stability and mechanic properties, are highlighted.
This highlight presents an update on applications of cocrystallization to modify properties relevant to efficacy, safety, and manufacturability of drugs. |
|---|---|
| AbstractList | Pharmaceutical cocrystallization affords an opportunity to modify the physicochemical properties of a solid-state drug without covalent modification of its molecular structure. This review presents an update on various applications of pharmaceutical cocrystallization with considerations on both cocrystals and salts, focusing on the property modification relevant to clinical efficacy and safety, and manufacturability of drugs. Some prominent examples of drug cocrystals/salts, which exhibit improved solubility and/or permeability and pharmacokinetics, stability and mechanic properties, are highlighted.
This highlight presents an update on applications of cocrystallization to modify properties relevant to efficacy, safety, and manufacturability of drugs. Pharmaceutical cocrystallization affords an opportunity to modify the physicochemical properties of a solid-state drug without covalent modification of its molecular structure. This review presents an update on various applications of pharmaceutical cocrystallization with considerations on both cocrystals and salts, focusing on the property modification relevant to clinical efficacy and safety, and manufacturability of drugs. Some prominent examples of drug cocrystals/salts, which exhibit improved solubility and/or permeability and pharmacokinetics, stability and mechanic properties, are highlighted. |
| Author | Dai, Xia-Lin Chen, Jia-Mei Lu, Tong-Bu |
| AuthorAffiliation | Institute for New Energy Materials and Low Carbon Technologies Tianjin University of Technology School of Chemistry and Chemical Engineering Sun Yat-Sen University School of Pharmaceutical Sciences |
| AuthorAffiliation_xml | – sequence: 0 name: Institute for New Energy Materials and Low Carbon Technologies – sequence: 0 name: Sun Yat-Sen University – sequence: 0 name: School of Chemistry and Chemical Engineering – sequence: 0 name: Tianjin University of Technology – sequence: 0 name: School of Pharmaceutical Sciences |
| Author_xml | – sequence: 1 givenname: Xia-Lin surname: Dai fullname: Dai, Xia-Lin – sequence: 2 givenname: Jia-Mei surname: Chen fullname: Chen, Jia-Mei – sequence: 3 givenname: Tong-Bu surname: Lu fullname: Lu, Tong-Bu |
| BookMark | eNptkc1LAzEQxYNUsFUv3oWAN2E1aTb74a2U-gEFPeh5GbITN2W7WZOsUv96Yysq4mVmDr_3ZngzIaPOdkjICWcXnInyUhUKGctZDntkzNMsSwomxOjXfEAm3q8Y4ynnbEzeHhpwa1A4BKOgpcoqt_EB2ta8QzC2u6LQUdQaVTCvSKHvnQXV0GDp2tZDCwFpaJD2zcabqG5wvTWKWI8uGPTUaupta-ok-ka6dsOzPyL7GlqPx1_9kDxdLx7nt8ny_uZuPlsmShRpSGotNUeVSa5FIWslkUPKSg2FEGnOsjIFLUsRK9ey1nnJUjUVWgrMQCpg4pCc7XzjPS8D-lCt7OC6uLKaciZjDLngkTrfUcpZ7x3qqndmDW5TcVZ9BlvNi_liG-wswuwPrEzYZhUcmPZ_yelO4rz6tv75lfgA6k6JPw |
| CitedBy_id | crossref_primary_10_1016_j_molstruc_2021_131560 crossref_primary_10_1039_D0CE00409J crossref_primary_10_1002_anie_202009467 crossref_primary_10_1016_j_cherd_2022_05_009 crossref_primary_10_1021_acs_cgd_3c00824 crossref_primary_10_1002_ajoc_201900594 crossref_primary_10_1021_acs_cgd_0c01043 crossref_primary_10_1021_acs_molpharmaceut_3c00398 crossref_primary_10_1080_00958972_2020_1734189 crossref_primary_10_1016_j_ijpharm_2021_121394 crossref_primary_10_1016_j_jcrysgro_2021_126241 crossref_primary_10_1021_acs_cgd_4c00555 crossref_primary_10_1007_s10904_023_02594_z crossref_primary_10_1073_pnas_2114277119 crossref_primary_10_1107_S2052520619013428 crossref_primary_10_1007_s40242_019_9116_3 crossref_primary_10_3390_pharmaceutics14091754 crossref_primary_10_1021_acs_jpcc_0c10560 crossref_primary_10_1021_acs_cgd_9b00939 crossref_primary_10_3390_cryst12101442 crossref_primary_10_34172_apb_2020_024 crossref_primary_10_1021_acs_cgd_9b01628 crossref_primary_10_1021_acs_cgd_3c00387 crossref_primary_10_1016_j_ejps_2023_106503 crossref_primary_10_1039_D1CE00785H crossref_primary_10_1039_D2CE00597B crossref_primary_10_1016_j_jddst_2021_102839 crossref_primary_10_1016_j_molstruc_2022_134402 crossref_primary_10_1016_j_molstruc_2020_129850 crossref_primary_10_1016_j_saa_2019_117170 crossref_primary_10_1107_S2053229621010883 crossref_primary_10_1007_s11094_024_03205_y crossref_primary_10_1039_D2NJ00453D crossref_primary_10_1039_D3CE00200D crossref_primary_10_1021_acs_cgd_4c00227 crossref_primary_10_1039_D2CE00872F crossref_primary_10_1016_j_ces_2020_116082 crossref_primary_10_2147_IJN_S426120 crossref_primary_10_1016_j_molstruc_2024_138124 crossref_primary_10_1002_crat_202300296 crossref_primary_10_1039_D4CE00039K crossref_primary_10_1080_03639045_2022_2122987 crossref_primary_10_1016_j_molstruc_2021_131387 crossref_primary_10_1016_j_tifs_2021_01_035 crossref_primary_10_1080_03639045_2020_1810270 crossref_primary_10_1016_j_ijpharm_2020_119694 crossref_primary_10_1016_j_ijpharm_2021_120246 crossref_primary_10_1021_acs_cgd_1c01352 crossref_primary_10_1021_acs_molpharmaceut_4c00393 crossref_primary_10_1039_D3CE00473B crossref_primary_10_1021_acs_iecr_3c02556 crossref_primary_10_3390_pharmaceutics13122140 crossref_primary_10_1016_j_cclet_2022_07_011 crossref_primary_10_1039_C9CE00666D crossref_primary_10_1080_03639045_2024_2306281 crossref_primary_10_1016_j_molstruc_2024_138577 crossref_primary_10_1002_ange_202009467 crossref_primary_10_1039_D0NJ05052K crossref_primary_10_1016_j_molstruc_2021_131770 crossref_primary_10_1021_acs_molpharmaceut_3c00524 crossref_primary_10_1039_D0CE01276A crossref_primary_10_1021_acs_cgd_1c00150 crossref_primary_10_1016_j_molstruc_2019_07_102 crossref_primary_10_1021_acs_cgd_1c01045 crossref_primary_10_3390_ph16101349 crossref_primary_10_1016_j_ijpharm_2021_120239 crossref_primary_10_1021_acs_cgd_9b00249 crossref_primary_10_1038_s42004_024_01380_3 crossref_primary_10_1039_D0CE01851A crossref_primary_10_1186_s43094_021_00213_7 crossref_primary_10_1021_acs_cgd_9b00763 crossref_primary_10_1021_acs_cgd_4c00401 crossref_primary_10_1016_j_bbrc_2024_150546 crossref_primary_10_1039_D1CE01327K crossref_primary_10_1007_s12247_020_09512_7 crossref_primary_10_3390_ph14060555 crossref_primary_10_1016_j_ijpharm_2020_119905 crossref_primary_10_1016_j_molstruc_2023_137353 crossref_primary_10_1016_j_jddst_2022_103732 |
| Cites_doi | 10.1016/0014-2999(87)90480-8 10.1021/acs.cgd.5b00439 10.1208/s12248-012-9337-6 10.1039/c3ce41188e 10.1038/clpt.1987.70 10.1517/17425247.2.6.1039 10.1021/cg400518w 10.1039/c3ce42008f 10.15171/apb.2016.062 10.1016/j.pcrysgrow.2016.07.001 10.4103/0250-474X.57283 10.1021/cg900129f 10.1039/C3CC47747A 10.1111/jphp.12384 10.1002/jps.22336 10.1016/S1773-2247(07)50090-0 10.1039/C6CE01835A 10.1007/s41745-017-0026-4 10.1016/j.ijpharm.2008.04.039 10.1021/acs.cgd.6b00266 10.1517/17425240902828304 10.1023/A:1026457729708 10.1016/j.ijpharm.2013.09.033 10.1002/cpt1977215610 10.1016/j.addr.2016.04.022 10.1016/j.ejps.2015.10.006 10.1021/es0606778 10.1016/j.addr.2017.07.001 10.1016/0378-5173(95)00088-Z 10.1254/jjp.60.91 10.1016/j.drudis.2013.08.013 10.1021/cg800035w 10.1371/journal.pone.0080437 10.1021/cg501247x 10.1039/C0CE00772B 10.1021/acs.cgd.5b00699 10.1021/acs.molpharmaceut.6b00134 10.1177/2042018814560735 10.1007/s12272-010-0301-7 10.1016/S1359-0286(97)80088-5 10.1039/c3ce41017j 10.1021/mp400516b 10.1007/s11095-011-0518-2 10.1079/PNS19960037 10.1016/j.addr.2011.07.007 10.1039/C6RA10917A 10.1039/c000614a 10.1016/j.addr.2017.07.008 10.1053/j.jvca.2005.12.011 10.1016/j.bmcl.2015.01.022 10.1517/17425255.2014.942281 10.1039/C4CE01921K 10.1056/NEJMoa020681 10.1016/j.addr.2017.03.003 10.1016/S1521-690X(03)00016-2 10.1039/C5CC08216A 10.1021/mp500719t 10.1021/op0000879 10.2174/138920010794328850 10.1021/cg300757k 10.1039/C7CC06992H 10.1002/jps.2600531108 10.1016/j.ejps.2017.04.008 10.1093/oxfordjournals.bja.a013395 10.1039/b007191i 10.1016/j.xphs.2016.09.009 10.1016/j.drudis.2008.03.004 10.1021/js970332a 10.1016/j.ijpharm.2016.04.068 10.1016/S1773-2247(14)50041-X 10.1016/j.addr.2003.10.020 10.1016/j.ijpharm.2005.04.004 10.1039/C4CE00103F 10.1001/jama.1972.03200260047014 10.1021/mp300169c 10.1021/mp200209j 10.1016/j.xphs.2016.10.021 10.1002/ptr.2899 10.1163/016942410X525678 10.1016/j.addr.2017.08.006 10.1021/cg500388s 10.1021/cg700843s 10.1155/2016/8135608 10.1021/cm00001a005 10.1021/cg201423q 10.1021/cg800764n 10.1016/j.bmcl.2007.09.064 10.1080/00498250701502114 10.1039/c2ce25724f 10.1039/C5CC10297A 10.1021/cg100514g 10.4103/0973-8398.72115 10.1517/17425255.1.4.739 10.1021/cg300327x 10.1016/j.addr.2017.03.002 10.1021/cg3010745 10.1016/j.ijpharm.2012.09.027 10.1016/j.ijpharm.2012.11.028 10.1021/cg500327s 10.1038/nbt.1504 10.1021/acs.cgd.6b00552 10.1093/jac/2.4.325 10.1039/C6CC01289B 10.1016/j.biopsych.2005.11.025 10.1021/acs.cgd.6b01863 10.2165/00003088-199936020-00003 10.2174/187221107782331629 10.1248/cpb.33.3738 10.1517/17425247.2013.747508 10.1002/jps.24048 10.1016/j.tips.2012.12.003 10.1021/acs.cgd.6b01540 10.1016/S0090-9556(25)06367-6 10.1016/j.ejps.2008.11.005 10.2174/1570163812666161201122452 10.1021/acs.molpharmaceut.5b00020 10.1021/acs.molpharmaceut.6b00532 10.1111/j.1751-1097.1995.tb02393.x 10.1211/0022357056244 10.1007/BF01062210 10.1002/anie.200700534 10.1021/mp4000794 10.1039/c3cs60014a 10.1016/j.ijpharm.2012.10.043 10.1039/B919819A 10.2174/09298673113209990120 |
| ContentType | Journal Article |
| Copyright | Copyright Royal Society of Chemistry 2018 |
| Copyright_xml | – notice: Copyright Royal Society of Chemistry 2018 |
| DBID | AAYXX CITATION 7U5 8FD L7M |
| DOI | 10.1039/c8ce00707a |
| DatabaseName | CrossRef Solid State and Superconductivity Abstracts Technology Research Database Advanced Technologies Database with Aerospace |
| DatabaseTitle | CrossRef Technology Research Database Advanced Technologies Database with Aerospace Solid State and Superconductivity Abstracts |
| DatabaseTitleList | CrossRef Technology Research Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering |
| EISSN | 1466-8033 |
| EndPage | 5316 |
| ExternalDocumentID | 10_1039_C8CE00707A c8ce00707a |
| GroupedDBID | -JG 0-7 0R~ 29F 5GY 6J9 705 70~ 7~J AAEMU AAIWI AAJAE AAMEH AANOJ AAWGC AAXHV AAXPP ABASK ABDVN ABEMK ABJNI ABPDG ABRYZ ABXOH ACGFO ACGFS ACLDK ADMRA ADSRN AEFDR AENEX AENGV AESAV AETIL AFLYV AFOGI AFVBQ AGEGJ AGKEF AGRSR AGSTE AHGCF ALMA_UNASSIGNED_HOLDINGS ANUXI APEMP ASKNT AUDPV AZFZN BLAPV BSQNT C6K CS3 E3Z EBS ECGLT EE0 EF- EJD GGIMP GNO H13 HZ~ H~N IDZ J3I N9A O9- OK1 P2P R7B RAOCF RCNCU RNS RPMJG RRA RRC RSCEA SKA SLH VH6 0UZ 1TJ 4.4 71~ AAYXX ACHDF ACRPL ADNMO AFRZK AGQPQ AHGXI AKMSF ALSGL ANBJS ANLMG ASPBG AVWKF BBWZM CAG CITATION COF EEHRC FEDTE HVGLF IDY J3G J3H L-8 M4U NDZJH R56 RCLXC ROL 7U5 8FD L7M |
| ID | FETCH-LOGICAL-c384t-df5f1ec651f385dc5e1a409fa833470694af5934af1f5df7904c23f53e6a5ca03 |
| ISSN | 1466-8033 |
| IngestDate | Mon Jun 30 05:19:10 EDT 2025 Thu Apr 24 23:04:35 EDT 2025 Thu Jul 10 08:14:02 EDT 2025 Tue Dec 17 21:00:37 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 36 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c384t-df5f1ec651f385dc5e1a409fa833470694af5934af1f5df7904c23f53e6a5ca03 |
| Notes | 2 reduction catalysts and pharmaceutical polymorphs and cocrystals. a crystal engineering based approach. Jia-Mei Chen currently serves as a professor in the School of Chemistry and Chemical Engineering at Tianjin University of Technology. She was born in 1979 and obtained her PhD (2008) from Sun Yat-Sen University under the supervision of Professor Tong-Bu Lu. After a short industrial stint as a chemist at Lonza R&D, China, she served as a faculty member at Yat-Sen University from 2010-2018. Her areas of research interest focus upon pharmaceutical cocrystallization and polymorphism Tong-Bu Lu (1964) obtained his B.S. in 1988 and PhD in 1993 under the supervision of Prof. Min-Yu Tan from Lanzhou University. After two years of postdoctoral fellowship at Sun Yat-Sen University, he joined the faculty at the same university and became a professor in 2000. He moved to Tianjin University of Technology in 2016. His current research interest lies in energy materials including water splitting and CO Xia-Lin Dai (1993) obtained her BSc in Pharmaceutical Science from Nankai University in 2015. Currently she is a PhD student at the School of Pharmaceutical Sciences, Sun Yat-Sen University, supervised by Professor Tong-Bu Lu. Her current research revolves around pharmaceutical cocrystallization, including cocrystals and salts, with the intention of improving the solubility and permeability of active pharmaceutical ingredients. via ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| ORCID | 0000-0002-6087-4880 0000-0002-3959-901X |
| PQID | 2105014731 |
| PQPubID | 2047491 |
| PageCount | 25 |
| ParticipantIDs | crossref_primary_10_1039_C8CE00707A rsc_primary_c8ce00707a crossref_citationtrail_10_1039_C8CE00707A proquest_journals_2105014731 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-00-00 |
| PublicationDateYYYYMMDD | 2018-01-01 |
| PublicationDate_xml | – year: 2018 text: 2018-00-00 |
| PublicationDecade | 2010 |
| PublicationPlace | Cambridge |
| PublicationPlace_xml | – name: Cambridge |
| PublicationTitle | CrystEngComm |
| PublicationYear | 2018 |
| Publisher | Royal Society of Chemistry |
| Publisher_xml | – name: Royal Society of Chemistry |
| References | Miroshnyk (C8CE00707A-(cit23)/*[position()=1]) 2009; 6 Xing (C8CE00707A-(cit81)/*[position()=1]) 2005; 57 Vioglio (C8CE00707A-(cit12)/*[position()=1]) 2017; 117 Amjadia (C8CE00707A-(cit108)/*[position()=1]) 2017; 17 Vangala (C8CE00707A-(cit127)/*[position()=1]) 2011; 13 Shan (C8CE00707A-(cit18)/*[position()=1]) 2008; 13 Shi (C8CE00707A-(cit89)/*[position()=1]) 2005; 2 Lennernäs (C8CE00707A-(cit114)/*[position()=1]) 1998; 87 Tanwar (C8CE00707A-(cit104)/*[position()=1]) 2016; 7 Chattoraj (C8CE00707A-(cit151)/*[position()=1]) 2014; 14 Kale (C8CE00707A-(cit98)/*[position()=1]) 2010; 24 Ita (C8CE00707A-(cit106)/*[position()=1]) 2014; 24 Ahmed (C8CE00707A-(cit84)/*[position()=1]) 2005; 1 Aakeroy (C8CE00707A-(cit22)/*[position()=1]) 2010; 12 Wang (C8CE00707A-(cit138)/*[position()=1]) 2014; 50 Gao (C8CE00707A-(cit142)/*[position()=1]) 2012; 438 Patel (C8CE00707A-(cit148)/*[position()=1]) 2016; 506 Suzawa (C8CE00707A-(cit128)/*[position()=1]) 1992; 60 Pruitt (C8CE00707A-(cit60)/*[position()=1]) 1977; 21 Onnainty (C8CE00707A-(cit99)/*[position()=1]) 2016; 13 Lin (C8CE00707A-(cit143)/*[position()=1]) 2016; 85 Ahmad (C8CE00707A-(cit132)/*[position()=1]) 2016; 2016 Yan (C8CE00707A-(cit65)/*[position()=1]) 2015; 17 Yan (C8CE00707A-(cit56)/*[position()=1]) 2012; 12 Sanphui (C8CE00707A-(cit77)/*[position()=1]) 2013; 10 Jambhekar (C8CE00707A-(cit45)/*[position()=1]) 2013; 18 Marcellin (C8CE00707A-(cit140)/*[position()=1]) 2003; 348 Morissettea (C8CE00707A-(cit32)/*[position()=1]) 2004; 56 Elder (C8CE00707A-(cit49)/*[position()=1]) 2013; 453 Peng (C8CE00707A-(cit62)/*[position()=1]) 2013; 458 Chamberlain (C8CE00707A-(cit126)/*[position()=1]) 1976; 2 Edhlund (C8CE00707A-(cit125)/*[position()=1]) 2006; 40 Davies (C8CE00707A-(cit86)/*[position()=1]) 1999; 36 Geng (C8CE00707A-(cit130)/*[position()=1]) 2013; 13 Huang (C8CE00707A-(cit82)/*[position()=1]) 2014; 103 Goud (C8CE00707A-(cit96)/*[position()=1]) 2014; 16 C8CE00707A-(cit74)/*[position()=1] Ross (C8CE00707A-(cit28)/*[position()=1]) 2016; 52 Gadade (C8CE00707A-(cit13)/*[position()=1]) 2016; 6 Wang (C8CE00707A-(cit73)/*[position()=1]) 2015; 25 Sun (C8CE00707A-(cit145)/*[position()=1]) 2008; 8 Mulvaney (C8CE00707A-(cit66)/*[position()=1]) 1972; 221 Friščić (C8CE00707A-(cit30)/*[position()=1]) 2009; 9 Xu (C8CE00707A-(cit72)/*[position()=1]) 2012; 12 Butters (C8CE00707A-(cit150)/*[position()=1]) 2001; 5 Steed (C8CE00707A-(cit1)/*[position()=1]) 2013; 34 Dai (C8CE00707A-(cit113)/*[position()=1]) 2016; 16 Pando (C8CE00707A-(cit33)/*[position()=1]) 2016; 6 (C8CE00707A-(cit39)/*[position()=1]) 2018 Aitipamula (C8CE00707A-(cit9)/*[position()=1]) 2014; 16 Deng (C8CE00707A-(cit122)/*[position()=1]) 2017; 104 Thakuria (C8CE00707A-(cit50)/*[position()=1]) 2013; 453 Shan (C8CE00707A-(cit70)/*[position()=1]) 2014; 10 Liakos (C8CE00707A-(cit120)/*[position()=1]) 2015; 6 Bikiaris (C8CE00707A-(cit90)/*[position()=1]) 2007; 1 Berry (C8CE00707A-(cit34)/*[position()=1]) 2008; 8 Hertog (C8CE00707A-(cit78)/*[position()=1]) 1996; 55 Malamatari (C8CE00707A-(cit29)/*[position()=1]) 2017; 117 Banasr (C8CE00707A-(cit54)/*[position()=1]) 2006; 59 Raja (C8CE00707A-(cit76)/*[position()=1]) 2006; 20 Agatonovic-Kustrin (C8CE00707A-(cit58)/*[position()=1]) 2008; 361 Sanphui (C8CE00707A-(cit149)/*[position()=1]) 2015; 12 Kuminek (C8CE00707A-(cit48)/*[position()=1]) 2016; 101 Duggirala (C8CE00707A-(cit20)/*[position()=1]) 2016; 52 Sun (C8CE00707A-(cit144)/*[position()=1]) 2011; 25 Otto (C8CE00707A-(cit3)/*[position()=1]) 2017; 14 Dittert (C8CE00707A-(cit59)/*[position()=1]) 1964; 53 Li (C8CE00707A-(cit35)/*[position()=1]) 2016; 13 Lee (C8CE00707A-(cit64)/*[position()=1]) 1995; 124 Desiraju (C8CE00707A-(cit21)/*[position()=1]) 2007; 46 Zacchigna (C8CE00707A-(cit71)/*[position()=1]) 2007; 17 Healy (C8CE00707A-(cit2)/*[position()=1]) 2017; 117 Prausnitz (C8CE00707A-(cit103)/*[position()=1]) 2008; 26 Wang (C8CE00707A-(cit139)/*[position()=1]) 2016; 52 Berry (C8CE00707A-(cit11)/*[position()=1]) 2017; 117 Sanphui (C8CE00707A-(cit101)/*[position()=1]) 2015; 12 Zhu (C8CE00707A-(cit83)/*[position()=1]) 2017; 17 Aufrère (C8CE00707A-(cit124)/*[position()=1]) 1978; 6 Desiraju (C8CE00707A-(cit6)/*[position()=1]) 1997; 2 Song (C8CE00707A-(cit53)/*[position()=1]) 2015; 15 Chen (C8CE00707A-(cit75)/*[position()=1]) 2016; 16 Chen (C8CE00707A-(cit57)/*[position()=1]) 2012; 14 Li (C8CE00707A-(cit61)/*[position()=1]) 2015; 15 Song (C8CE00707A-(cit52)/*[position()=1]) 2014; 14 Thompson (C8CE00707A-(cit85)/*[position()=1]) 2000; 84 Cherukuvada (C8CE00707A-(cit7)/*[position()=1]) 2016; 18 Yan (C8CE00707A-(cit111)/*[position()=1]) 2013; 15 Varma (C8CE00707A-(cit116)/*[position()=1]) 2010; 11 Gandhi (C8CE00707A-(cit51)/*[position()=1]) 2013; 8 Hull (C8CE00707A-(cit94)/*[position()=1]) 2004; 73 Labler (C8CE00707A-(cit135)/*[position()=1]) 1996 Weyna (C8CE00707A-(cit88)/*[position()=1]) 2012; 9 Bell (C8CE00707A-(cit136)/*[position()=1]) 1978 Kale (C8CE00707A-(cit14)/*[position()=1]) 2017; 106 Shan (C8CE00707A-(cit38)/*[position()=1]) 2008; 13 Reiter (C8CE00707A-(cit63)/*[position()=1]) 2003; 17 Smith (C8CE00707A-(cit97)/*[position()=1]) 2013; 10 Tao (C8CE00707A-(cit69)/*[position()=1]) 2013; 15 Etter (C8CE00707A-(cit5)/*[position()=1]) 1989; 1 Schultheiss (C8CE00707A-(cit42)/*[position()=1]) 2009; 9 Mogilnicka (C8CE00707A-(cit131)/*[position()=1]) 1987; 138 Yuan (C8CE00707A-(cit141)/*[position()=1]) 2000; 17 Apshingekar (C8CE00707A-(cit36)/*[position()=1]) 2017; 106 Shi (C8CE00707A-(cit147)/*[position()=1]) 2011; 28 McCrone (C8CE00707A-(cit37)/*[position()=1]) 1965 Amo (C8CE00707A-(cit115)/*[position()=1]) 2009; 36 Yadav (C8CE00707A-(cit10)/*[position()=1]) 2009; 71 Yu (C8CE00707A-(cit134)/*[position()=1]) 2017; 53 Braga (C8CE00707A-(cit31)/*[position()=1]) 2013; 42 (C8CE00707A-(cit40)/*[position()=1]) 2015 Dahan (C8CE00707A-(cit43)/*[position()=1]) 2012; 14 Mathur (C8CE00707A-(cit107)/*[position()=1]) 2010; 4 Sun (C8CE00707A-(cit8)/*[position()=1]) 2013; 10 Lennernäs (C8CE00707A-(cit46)/*[position()=1]) 2007; 17 Chattoraj (C8CE00707A-(cit146)/*[position()=1]) 2010; 12 Tan (C8CE00707A-(cit137)/*[position()=1]) 2000 Cai (C8CE00707A-(cit79)/*[position()=1]) 2013; 20 Dokoumetzidis (C8CE00707A-(cit44)/*[position()=1]) 2007; 37 Gopi (C8CE00707A-(cit102)/*[position()=1]) 2017; 17 Smith (C8CE00707A-(cit80)/*[position()=1]) 2011; 8 Wang (C8CE00707A-(cit119)/*[position()=1]) 2012; 12 Gadade (C8CE00707A-(cit19)/*[position()=1]) 2016; 6 Douroumis (C8CE00707A-(cit15)/*[position()=1]) 2017; 117 Domingosa (C8CE00707A-(cit4)/*[position()=1]) 2015; 67 C8CE00707A-(cit110)/*[position()=1] Vries (C8CE00707A-(cit133)/*[position()=1]) 2010; 62 Kakegawa (C8CE00707A-(cit129)/*[position()=1]) 1985; 33 Aitipamula (C8CE00707A-(cit16)/*[position()=1]) 2017; 97 Tao (C8CE00707A-(cit68)/*[position()=1]) 2012; 12 Cheney (C8CE00707A-(cit87)/*[position()=1]) 2010; 10 Chen (C8CE00707A-(cit93)/*[position()=1]) 2014; 14 Douroumis (C8CE00707A-(cit27)/*[position()=1]) 2017; 117 Singh (C8CE00707A-(cit112)/*[position()=1]) 2005; 298 Bavishi (C8CE00707A-(cit47)/*[position()=1]) 2016; 62 Laskin (C8CE00707A-(cit92)/*[position()=1]) 1987; 41 Schultheiss (C8CE00707A-(cit17)/*[position()=1]) 2009; 9 Watari (C8CE00707A-(cit123)/*[position()=1]) 1983; 11 Subedi (C8CE00707A-(cit105)/*[position()=1]) 2010; 33 Lutker (C8CE00707A-(cit109)/*[position()=1]) 2011; 100 Tamai (C8CE00707A-(cit117)/*[position()=1]) 2012; 64 |
| References_xml | – issn: 2015 publication-title: Reflection paper on the use of cocrystals of active substances in medicinal products – issn: 2018 publication-title: Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry – issn: 1965 end-page: 2 publication-title: Physics and Chemistry of the Organic Solid State doi: McCrone – issn: 2005 publication-title: US doi: Kerrish Bergeron Augsburger – issn: 1996 publication-title: Ullmann's Encyclopedia of Industrial Chemistry doi: Labler – issn: 2010 doi: Bonneville Fahmi Hecht Roy – publication-title: Assessment Report for Eliquis; Procedure No. EMEA/H/C/002148 – issn: 1978 end-page: p 1-50 publication-title: The chemistry of the vitamins D, in Vitamin D doi: Bell – issn: 2010 publication-title: CN doi: Rong Jin Feng Li Li You Pang Xu Ye – issn: 2009 publication-title: CN doi: Zhang Shan Yuan Jiang Huang Wang Cao Cheng Pan Yu – issn: 2008 publication-title: US doi: Gougoutas Lobinger Ramakrishnan Deshpande Bien Lai Wang Riebel Grosso Nirschl Singh DiMarco – volume: 138 start-page: 413 year: 1987 ident: C8CE00707A-(cit131)/*[position()=1] publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(87)90480-8 – ident: C8CE00707A-(cit110)/*[position()=1] – volume: 15 start-page: 3785 year: 2015 ident: C8CE00707A-(cit61)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/acs.cgd.5b00439 – volume: 14 start-page: 244 year: 2012 ident: C8CE00707A-(cit43)/*[position()=1] publication-title: AAPS J. doi: 10.1208/s12248-012-9337-6 – volume: 15 start-page: 7852 year: 2013 ident: C8CE00707A-(cit69)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/c3ce41188e – volume: 41 start-page: 546 year: 1987 ident: C8CE00707A-(cit92)/*[position()=1] publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.1987.70 – volume: 2 start-page: 1039 year: 2005 ident: C8CE00707A-(cit89)/*[position()=1] publication-title: Expert Opin. Drug Delivery doi: 10.1517/17425247.2.6.1039 – volume: 13 start-page: 3546 year: 2013 ident: C8CE00707A-(cit130)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg400518w – volume: 16 start-page: 3451 year: 2014 ident: C8CE00707A-(cit9)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/c3ce42008f – volume: 6 start-page: 479 year: 2016 ident: C8CE00707A-(cit13)/*[position()=1] publication-title: Adv. Pharm. Bull. doi: 10.15171/apb.2016.062 – volume: 62 start-page: 1 year: 2016 ident: C8CE00707A-(cit47)/*[position()=1] publication-title: Prog. Cryst. Growth Charact. Mater. doi: 10.1016/j.pcrysgrow.2016.07.001 – volume: 71 start-page: 359 year: 2009 ident: C8CE00707A-(cit10)/*[position()=1] publication-title: Indian J. Pharm. Sci. doi: 10.4103/0250-474X.57283 – volume: 9 start-page: 2950 year: 2009 ident: C8CE00707A-(cit17)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg900129f – volume: 50 start-page: 855 year: 2014 ident: C8CE00707A-(cit138)/*[position()=1] publication-title: Chem. Commun. doi: 10.1039/C3CC47747A – volume: 67 start-page: 830 year: 2015 ident: C8CE00707A-(cit4)/*[position()=1] publication-title: J. Pharm. Pharmacol. doi: 10.1111/jphp.12384 – volume: 100 start-page: 949 year: 2011 ident: C8CE00707A-(cit109)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1002/jps.22336 – volume: 17 start-page: 237 year: 2007 ident: C8CE00707A-(cit46)/*[position()=1] publication-title: J. Drug Delivery Sci. Technol. doi: 10.1016/S1773-2247(07)50090-0 – volume: 18 start-page: 8528 year: 2016 ident: C8CE00707A-(cit7)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/C6CE01835A – volume: 97 start-page: 227 year: 2017 ident: C8CE00707A-(cit16)/*[position()=1] publication-title: J. Indian Inst. Sci. doi: 10.1007/s41745-017-0026-4 – volume: 361 start-page: 245 year: 2008 ident: C8CE00707A-(cit58)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2008.04.039 – volume: 16 start-page: 2923 year: 2016 ident: C8CE00707A-(cit75)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/acs.cgd.6b00266 – volume: 6 start-page: 333 year: 2009 ident: C8CE00707A-(cit23)/*[position()=1] publication-title: Expert Opin. Drug Delivery doi: 10.1517/17425240902828304 – volume: 17 start-page: 139 year: 2017 ident: C8CE00707A-(cit108)/*[position()=1] publication-title: Curr. Gene Ther. – volume: 17 start-page: 1098 year: 2000 ident: C8CE00707A-(cit141)/*[position()=1] publication-title: Pharm. Res. doi: 10.1023/A:1026457729708 – volume: 458 start-page: 156 year: 2013 ident: C8CE00707A-(cit62)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.09.033 – volume: 21 start-page: 610 year: 1977 ident: C8CE00707A-(cit60)/*[position()=1] publication-title: Clin. Pharmacol. Ther. doi: 10.1002/cpt1977215610 – volume: 101 start-page: 143 year: 2016 ident: C8CE00707A-(cit48)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2016.04.022 – volume: 85 start-page: 141 year: 2016 ident: C8CE00707A-(cit143)/*[position()=1] publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2015.10.006 – volume: 40 start-page: 5422 year: 2006 ident: C8CE00707A-(cit125)/*[position()=1] publication-title: Environ. Sci. Technol. doi: 10.1021/es0606778 – volume: 117 start-page: 86 year: 2017 ident: C8CE00707A-(cit12)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2017.07.001 – volume: 124 start-page: 119 year: 1995 ident: C8CE00707A-(cit64)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)00088-Z – volume: 60 start-page: 91 year: 1992 ident: C8CE00707A-(cit128)/*[position()=1] publication-title: Jpn. J. Pharmacol. doi: 10.1254/jjp.60.91 – volume: 18 start-page: 1173 year: 2013 ident: C8CE00707A-(cit45)/*[position()=1] publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2013.08.013 – volume: 8 start-page: 1697 year: 2008 ident: C8CE00707A-(cit34)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg800035w – volume: 8 start-page: e80437 year: 2013 ident: C8CE00707A-(cit51)/*[position()=1] publication-title: PLoS One doi: 10.1371/journal.pone.0080437 – volume: 14 start-page: 6399 year: 2014 ident: C8CE00707A-(cit93)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg501247x – volume: 13 start-page: 759 year: 2011 ident: C8CE00707A-(cit127)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/C0CE00772B – volume: 15 start-page: 4869 year: 2015 ident: C8CE00707A-(cit53)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/acs.cgd.5b00699 – volume: 13 start-page: 3054 year: 2016 ident: C8CE00707A-(cit35)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/acs.molpharmaceut.6b00134 – volume: 6 start-page: 61 year: 2015 ident: C8CE00707A-(cit120)/*[position()=1] publication-title: Ther. Adv. Endocrinol. Metab. doi: 10.1177/2042018814560735 – volume: 33 start-page: 339 year: 2010 ident: C8CE00707A-(cit105)/*[position()=1] publication-title: Arch. Pharmacal Res. doi: 10.1007/s12272-010-0301-7 – volume: 2 start-page: 451 year: 1997 ident: C8CE00707A-(cit6)/*[position()=1] publication-title: Curr. Opin. Solid State Mater. Sci. doi: 10.1016/S1359-0286(97)80088-5 – volume: 73 start-page: 425 year: 2004 ident: C8CE00707A-(cit94)/*[position()=1] publication-title: Cutis – volume: 15 start-page: 6457 year: 2013 ident: C8CE00707A-(cit111)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/c3ce41017j – volume: 10 start-page: 4687 year: 2013 ident: C8CE00707A-(cit77)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/mp400516b – volume: 28 start-page: 3248 year: 2011 ident: C8CE00707A-(cit147)/*[position()=1] publication-title: Pharm. Res. doi: 10.1007/s11095-011-0518-2 – volume: 55 start-page: 385 year: 1996 ident: C8CE00707A-(cit78)/*[position()=1] publication-title: Proc. Nutr. Soc. doi: 10.1079/PNS19960037 – volume: 64 start-page: 508 year: 2012 ident: C8CE00707A-(cit117)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2011.07.007 – volume: 6 start-page: 71134 year: 2016 ident: C8CE00707A-(cit33)/*[position()=1] publication-title: RSC Adv. doi: 10.1039/C6RA10917A – volume: 12 start-page: 2466 year: 2010 ident: C8CE00707A-(cit146)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/c000614a – volume: 117 start-page: 178 year: 2017 ident: C8CE00707A-(cit27)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2017.07.008 – volume: 20 start-page: 722 year: 2006 ident: C8CE00707A-(cit76)/*[position()=1] publication-title: J. Cardiothorac. Vasc. Anesth. doi: 10.1053/j.jvca.2005.12.011 – volume: 25 start-page: 1036 year: 2015 ident: C8CE00707A-(cit73)/*[position()=1] publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2015.01.022 – volume: 10 start-page: 1255 year: 2014 ident: C8CE00707A-(cit70)/*[position()=1] publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.2014.942281 – volume: 17 start-page: 612 year: 2015 ident: C8CE00707A-(cit65)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/C4CE01921K – volume: 348 start-page: 808 year: 2003 ident: C8CE00707A-(cit140)/*[position()=1] publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa020681 – volume: 117 start-page: 3 year: 2017 ident: C8CE00707A-(cit11)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2017.03.003 – volume: 17 start-page: 273 year: 2003 ident: C8CE00707A-(cit63)/*[position()=1] publication-title: Best Pract. Res., Clin. Endocrinol. Metab. doi: 10.1016/S1521-690X(03)00016-2 – volume: 52 start-page: 640 year: 2016 ident: C8CE00707A-(cit20)/*[position()=1] publication-title: Chem. Commun. doi: 10.1039/C5CC08216A – volume: 12 start-page: 889 year: 2015 ident: C8CE00707A-(cit149)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/mp500719t – volume: 5 start-page: 28 year: 2001 ident: C8CE00707A-(cit150)/*[position()=1] publication-title: Org. Process Res. Dev. doi: 10.1021/op0000879 – volume: 11 start-page: 730 year: 2010 ident: C8CE00707A-(cit116)/*[position()=1] publication-title: Curr. Drug Metab. doi: 10.2174/138920010794328850 – volume: 12 start-page: 4562 year: 2012 ident: C8CE00707A-(cit119)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg300757k – volume: 53 start-page: 12266 year: 2017 ident: C8CE00707A-(cit134)/*[position()=1] publication-title: Chem. Commun. doi: 10.1039/C7CC06992H – volume: 53 start-page: 1325 year: 1964 ident: C8CE00707A-(cit59)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600531108 – volume: 104 start-page: 255 year: 2017 ident: C8CE00707A-(cit122)/*[position()=1] publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2017.04.008 – volume: 84 start-page: 151 year: 2000 ident: C8CE00707A-(cit85)/*[position()=1] publication-title: Br. J. Anaesth. doi: 10.1093/oxfordjournals.bja.a013395 – start-page: 2345 year: 2000 ident: C8CE00707A-(cit137)/*[position()=1] publication-title: Chem. Commun. doi: 10.1039/b007191i – volume: 106 start-page: 66 year: 2017 ident: C8CE00707A-(cit36)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2016.09.009 – volume: 13 start-page: 440 year: 2008 ident: C8CE00707A-(cit18)/*[position()=1] publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2008.03.004 – start-page: 2 volume-title: Physics and Chemistry of the Organic Solid State year: 1965 ident: C8CE00707A-(cit37)/*[position()=1] – volume: 7 start-page: 2274 year: 2016 ident: C8CE00707A-(cit104)/*[position()=1] publication-title: Int. J. Pharm. Sci. Res. – volume: 87 start-page: 403 year: 1998 ident: C8CE00707A-(cit114)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1021/js970332a – volume: 506 start-page: 262 year: 2016 ident: C8CE00707A-(cit148)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2016.04.068 – volume: 24 start-page: 245 year: 2014 ident: C8CE00707A-(cit106)/*[position()=1] publication-title: J. Drug Delivery Sci. Technol. doi: 10.1016/S1773-2247(14)50041-X – volume: 56 start-page: 275 year: 2004 ident: C8CE00707A-(cit32)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2003.10.020 – volume: 117 start-page: 178 year: 2017 ident: C8CE00707A-(cit15)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2017.07.008 – volume: 298 start-page: 98 year: 2005 ident: C8CE00707A-(cit112)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.04.004 – volume: 16 start-page: 5859 year: 2014 ident: C8CE00707A-(cit96)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/C4CE00103F – volume: 221 start-page: 1511 year: 1972 ident: C8CE00707A-(cit66)/*[position()=1] publication-title: JAMA, J. Am. Med. Assoc. doi: 10.1001/jama.1972.03200260047014 – volume: 9 start-page: 2094 year: 2012 ident: C8CE00707A-(cit88)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/mp300169c – volume: 8 start-page: 1867 year: 2011 ident: C8CE00707A-(cit80)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/mp200209j – volume-title: Ullmann's Encyclopedia of Industrial Chemistry year: 1996 ident: C8CE00707A-(cit135)/*[position()=1] – volume: 106 start-page: 457 year: 2017 ident: C8CE00707A-(cit14)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2016.10.021 – volume-title: Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry year: 2018 ident: C8CE00707A-(cit39)/*[position()=1] – volume: 24 start-page: S48 year: 2010 ident: C8CE00707A-(cit98)/*[position()=1] publication-title: Phytother. Res. doi: 10.1002/ptr.2899 – volume: 25 start-page: 483 year: 2011 ident: C8CE00707A-(cit144)/*[position()=1] publication-title: J. Adhes. Sci. Technol. doi: 10.1163/016942410X525678 – volume: 117 start-page: 162 year: 2017 ident: C8CE00707A-(cit29)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2017.08.006 – volume: 14 start-page: 3864 year: 2014 ident: C8CE00707A-(cit151)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg500388s – volume: 8 start-page: 1575 year: 2008 ident: C8CE00707A-(cit145)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg700843s – volume: 2016 start-page: 1 year: 2016 ident: C8CE00707A-(cit132)/*[position()=1] publication-title: Int. J. Photoenergy doi: 10.1155/2016/8135608 – volume: 1 start-page: 10 year: 1989 ident: C8CE00707A-(cit5)/*[position()=1] publication-title: Chem. Mater. doi: 10.1021/cm00001a005 – volume: 12 start-page: 2226 year: 2012 ident: C8CE00707A-(cit56)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg201423q – volume: 9 start-page: 1621 year: 2009 ident: C8CE00707A-(cit30)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg800764n – volume: 9 start-page: 2950 year: 2009 ident: C8CE00707A-(cit42)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg900129f – volume: 17 start-page: 6607 year: 2007 ident: C8CE00707A-(cit71)/*[position()=1] publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2007.09.064 – volume: 37 start-page: 1052 year: 2007 ident: C8CE00707A-(cit44)/*[position()=1] publication-title: Xenobiotica doi: 10.1080/00498250701502114 – volume: 14 start-page: 6221 year: 2012 ident: C8CE00707A-(cit57)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/c2ce25724f – volume: 52 start-page: 3572 year: 2016 ident: C8CE00707A-(cit139)/*[position()=1] publication-title: Chem. Commun. doi: 10.1039/C5CC10297A – volume: 10 start-page: 4401 year: 2010 ident: C8CE00707A-(cit87)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg100514g – volume: 4 start-page: 173 year: 2010 ident: C8CE00707A-(cit107)/*[position()=1] publication-title: Asian J. Pharm. doi: 10.4103/0973-8398.72115 – volume: 1 start-page: 739 year: 2005 ident: C8CE00707A-(cit84)/*[position()=1] publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.1.4.739 – volume: 12 start-page: 3144 year: 2012 ident: C8CE00707A-(cit68)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg300327x – volume: 117 start-page: 25 year: 2017 ident: C8CE00707A-(cit2)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2017.03.002 – volume: 12 start-page: 6004 year: 2012 ident: C8CE00707A-(cit72)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg3010745 – volume: 438 start-page: 327 year: 2012 ident: C8CE00707A-(cit142)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2012.09.027 – volume: 453 start-page: 88 year: 2013 ident: C8CE00707A-(cit49)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2012.11.028 – volume: 14 start-page: 3069 year: 2014 ident: C8CE00707A-(cit52)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/cg500327s – volume: 26 start-page: 1261 year: 2008 ident: C8CE00707A-(cit103)/*[position()=1] publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1504 – volume-title: Assessment Report for Eliquis; Procedure No. EMEA/H/C/002148 ident: C8CE00707A-(cit74)/*[position()=1] – volume-title: Reflection paper on the use of cocrystals of active substances in medicinal products year: 2015 ident: C8CE00707A-(cit40)/*[position()=1] – volume: 16 start-page: 4430 year: 2016 ident: C8CE00707A-(cit113)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/acs.cgd.6b00552 – volume: 2 start-page: 325 year: 1976 ident: C8CE00707A-(cit126)/*[position()=1] publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/2.4.325 – volume: 52 start-page: 8772 year: 2016 ident: C8CE00707A-(cit28)/*[position()=1] publication-title: Chem. Commun. doi: 10.1039/C6CC01289B – volume: 59 start-page: 1087 year: 2006 ident: C8CE00707A-(cit54)/*[position()=1] publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2005.11.025 – volume: 17 start-page: 1893 year: 2017 ident: C8CE00707A-(cit83)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/acs.cgd.6b01863 – volume: 36 start-page: 115 year: 1999 ident: C8CE00707A-(cit86)/*[position()=1] publication-title: Clin. Pharmacokinet. doi: 10.2165/00003088-199936020-00003 – volume: 1 start-page: 201 year: 2007 ident: C8CE00707A-(cit90)/*[position()=1] publication-title: Recent Pat. Drug Delivery Formulation doi: 10.2174/187221107782331629 – volume: 33 start-page: 3738 year: 1985 ident: C8CE00707A-(cit129)/*[position()=1] publication-title: Chem. Pharm. Bull. doi: 10.1248/cpb.33.3738 – volume: 10 start-page: 201 year: 2013 ident: C8CE00707A-(cit8)/*[position()=1] publication-title: Expert Opin. Drug Delivery doi: 10.1517/17425247.2013.747508 – volume: 103 start-page: 2330 year: 2014 ident: C8CE00707A-(cit82)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1002/jps.24048 – volume: 34 start-page: 185 year: 2013 ident: C8CE00707A-(cit1)/*[position()=1] publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2012.12.003 – volume: 17 start-page: 308 year: 2017 ident: C8CE00707A-(cit102)/*[position()=1] publication-title: Cryst. Growth Des. doi: 10.1021/acs.cgd.6b01540 – volume: 6 start-page: 403 year: 1978 ident: C8CE00707A-(cit124)/*[position()=1] publication-title: Drug Metab. Dispos. doi: 10.1016/S0090-9556(25)06367-6 – volume: 36 start-page: 200 year: 2009 ident: C8CE00707A-(cit115)/*[position()=1] publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2008.11.005 – volume: 14 start-page: 72 year: 2017 ident: C8CE00707A-(cit3)/*[position()=1] publication-title: Curr. Drug Discovery Technol. doi: 10.2174/1570163812666161201122452 – volume: 6 start-page: 479 year: 2016 ident: C8CE00707A-(cit19)/*[position()=1] publication-title: Adv. Pharm. Bull. doi: 10.15171/apb.2016.062 – volume: 12 start-page: 1615 year: 2015 ident: C8CE00707A-(cit101)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/acs.molpharmaceut.5b00020 – volume: 13 start-page: 3736 year: 2016 ident: C8CE00707A-(cit99)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/acs.molpharmaceut.6b00532 – volume: 62 start-page: 959 year: 2010 ident: C8CE00707A-(cit133)/*[position()=1] publication-title: Photochem. Photobiol. doi: 10.1111/j.1751-1097.1995.tb02393.x – volume: 57 start-page: 743 year: 2005 ident: C8CE00707A-(cit81)/*[position()=1] publication-title: J. Pharm. Pharmacol. doi: 10.1211/0022357056244 – volume: 11 start-page: 529 year: 1983 ident: C8CE00707A-(cit123)/*[position()=1] publication-title: J. Pharmacokinet. Biopharm. doi: 10.1007/BF01062210 – volume: 46 start-page: 8342 year: 2007 ident: C8CE00707A-(cit21)/*[position()=1] publication-title: Angew. Chem., Int. Ed. doi: 10.1002/anie.200700534 – volume: 10 start-page: 2948 year: 2013 ident: C8CE00707A-(cit97)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/mp4000794 – volume: 13 start-page: 440 year: 2008 ident: C8CE00707A-(cit38)/*[position()=1] publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2008.03.004 – volume-title: The chemistry of the vitamins D, in Vitamin D year: 1978 ident: C8CE00707A-(cit136)/*[position()=1] – volume: 42 start-page: 7638 year: 2013 ident: C8CE00707A-(cit31)/*[position()=1] publication-title: Chem. Soc. Rev. doi: 10.1039/c3cs60014a – volume: 453 start-page: 101 year: 2013 ident: C8CE00707A-(cit50)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2012.10.043 – volume: 12 start-page: 22 year: 2010 ident: C8CE00707A-(cit22)/*[position()=1] publication-title: CrystEngComm doi: 10.1039/B919819A – volume: 20 start-page: 2572 year: 2013 ident: C8CE00707A-(cit79)/*[position()=1] publication-title: Curr. Med. Chem. doi: 10.2174/09298673113209990120 |
| SSID | ssj0014110 |
| Score | 2.499498 |
| Snippet | Pharmaceutical cocrystallization affords an opportunity to modify the physicochemical properties of a solid-state drug without covalent modification of its... |
| SourceID | proquest crossref rsc |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 5292 |
| SubjectTerms | Cocrystallization Drugs Manufacturability Molecular structure Pharmaceuticals Solid state |
| Title | Pharmaceutical cocrystallization: an effective approach to modulate the physicochemical properties of solid-state drugs |
| URI | https://www.proquest.com/docview/2105014731 |
| Volume | 2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLZYd4ED4tdE2UCW4IKQRxLHicNtVEUDbYhDJ_UWOY69VSrJFFJN8Nfz7NhJuvUwuFiVFadKvs_Pzy9-30PoXapoqINAEh1qTWKVZUQEVJFCcNj2aMWVNgH98-_J6UX8bcmWQzDHZpe0xbH8szOv5H9QhT7A1WTJ_gOy_U2hA34DvtACwtDeC-MfV1sBabBtzW_w9tZrl1xpM5krd2bDHBHyCuLG4_xZl6Z0l-qSpSxcpnpWJx9wbWL0jRFbNd4kPMWqJDb36EPZbFxo3esbmP-cV5cm1WSIe9tDAsuVIGernn4znwkC3edq1Z8F2ljS1NUl-bwZRyG2TGacGEnjTs7iWO3oc3Y2CkZ8omOryaKuHp5bgcEsJDute0CNOOqMz-ZWpajXRx0ktG8tbf2BQ_upnWb5MHYP7Uews4gmaP9kvvh61n96isNOwsI_gte0pdnHYfS2FzNsTfYaXzfG-ieLJ-ix21jgk44lT9EDVT1Dj0Zyk8_RzTZf8B2-fMKiwj1bsGcLbmvs2YKBLfgWW_DAFlxrPGILtmx5gS6-zBezU-IKbxBJedySUjMdKpmwUFPOSslUKOIg04JTGqcmVVpollFoQ81KnWZBLGFiM6oSwSTM9QM0qepKvUQ4yyKZ8EIU4IzF4AoXKaxomhWRYJyXvJii9_5F5tKp0pviKOv8LmRT9La_9rrTYtl51ZHHI3dz9VcewTYCoE1pOEUHgFE_XnKp7Djx6l53P0QPDf27INwRmrTNRr0Gt7Qt3jgi_QXI6ZDl |
| linkProvider | Royal Society of Chemistry |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmaceutical+cocrystallization%3A+an+effective+approach+to+modulate+the+physicochemical+properties+of+solid-state+drugs&rft.jtitle=CrystEngComm&rft.au=Dai%2C+Xia-Lin&rft.au=Chen%2C+Jia-Mei&rft.au=Lu%2C+Tong-Bu&rft.date=2018&rft.issn=1466-8033&rft.eissn=1466-8033&rft.volume=20&rft.issue=36&rft.spage=5292&rft.epage=5316&rft_id=info:doi/10.1039%2FC8CE00707A&rft.externalDBID=n%2Fa&rft.externalDocID=10_1039_C8CE00707A |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1466-8033&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1466-8033&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1466-8033&client=summon |